Log in to save to my catalogue

cis -Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy...

cis -Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1419365822

cis -Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach

About this item

Full title

cis -Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach

Publisher

Berlin: Springer

Journal title

Journal of cancer research and clinical oncology, 1998-01, Vol.124 (1), p.37-43

Language

English

Formats

Publication information

Publisher

Berlin: Springer

More information

Scope and Contents

Contents

The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions fro...

Alternative Titles

Full title

cis -Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1419365822

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1419365822

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s004320050131

How to access this item